| scholarly article | Q13442814 |
| P50 | author | Trevor J. Orchard | Q30223717 |
| Diabetes Prevention Program Research Group | Q47171583 | ||
| Abbas E Kitabchi | Q62995074 | ||
| Richard F. Hamman | Q64454798 | ||
| P2093 | author name string | Kieren J Mather | |
| Ronald B Goldberg | |||
| Maria G Montez | |||
| Leigh Perreault | |||
| Marinella Temprosa | |||
| Mary Larkin | |||
| Debra Thayer | |||
| Ed Horton | |||
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study | Q24633604 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
| Glucose control and vascular complications in veterans with type 2 diabetes | Q29619213 | ||
| Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program | Q30489774 | ||
| Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study | Q30533186 | ||
| Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes | Q30548796 | ||
| Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial | Q33425402 | ||
| Does weight loss cause the exercise-induced increase in plasma high density lipoproteins? | Q33651546 | ||
| Effects of acute exercise on postprandial triglyceride response after a high-fat meal in overweight black and white adolescents. | Q33669481 | ||
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
| Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials | Q33958254 | ||
| XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients | Q33974818 | ||
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial | Q33999757 | ||
| A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? | Q36081354 | ||
| Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study | Q36472753 | ||
| The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program | Q36496751 | ||
| Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes | Q36805400 | ||
| The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial | Q36825706 | ||
| An R2 statistic for fixed effects in the linear mixed model | Q36984762 | ||
| Changes in insulin resistance and HbA1c are related to exercise-mediated changes in body composition in older adults with type 2 diabetes: interim outcomes from the GREAT2DO trial. | Q37022614 | ||
| The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. | Q37022665 | ||
| Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Resear | Q37139552 | ||
| Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds | Q37400796 | ||
| Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence | Q37719077 | ||
| Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. | Q39830081 | ||
| Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial | Q43606926 | ||
| Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | Q43742848 | ||
| Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women | Q44114894 | ||
| Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome | Q46329839 | ||
| Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. | Q46881268 | ||
| Relative effects of weight loss and dietary fat modification on serum lipid levels in the dietary treatment of obesity | Q47383833 | ||
| Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study | Q50546299 | ||
| Pioglitazone for diabetes prevention in impaired glucose tolerance | Q51161029 | ||
| The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes | Q56341913 | ||
| Is regression to normoglycaemia clinically important? | Q58039585 | ||
| The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group | Q59236664 | ||
| The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I | Q68126008 | ||
| Prevention of heart disease in general practice: the use of a risk score | Q74736191 | ||
| Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association | Q78057327 | ||
| HEXOKINASE OF ESCHERICHIA COLI. ASSAY OF ENZYME ACTIVITY AND ADAPTATION TO GROWTH IN VARIOUS MEDIA | Q78321383 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| prevention | Q1717246 | ||
| P304 | page(s) | 2622-2631 | |
| P577 | publication date | 2014-06-26 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study | |
| P478 | volume | 37 |
| Q47233232 | 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial |
| Q40098483 | Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes? |
| Q58102155 | Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia |
| Q64068434 | Different Contributions of Dyslipidemia and Obesity to the Natural History of Type 2 Diabetes: 3-Year Cohort Study in China |
| Q47139121 | Effect of a vitamin and mineral supplementation on glycemic status: Results from a community-based program |
| Q89719705 | Effects of A 12-Month Intensive Lifestyle Monitoring Program in Predominantly Overweight/Obese Arab Adults with Prediabetes |
| Q40285821 | Elevated serum complement C3 levels are related to the development of prediabetes in an adult population: the Tianjin Chronic Low-Grade Systematic Inflammation and Health Cohort Study |
| Q38393219 | Evaluation of lorcaserin on progression of prediabetes to type 2 diabetes and reversion to euglycemia |
| Q53578997 | Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: a prospective cohort study. |
| Q55257273 | Impact of a 12-week wellness coaching on self-care behaviors among primary care adult patients with prediabetes. |
| Q51289105 | Incident Type 2 diabetes and the effect of early regression to normoglycaemia in a population with impaired glucose regulation. |
| Q35584102 | Individuals with prediabetes identified by HbA1c undergoing coronary angiography have worse cardiometabolic profile than those identified by fasting glucose |
| Q92226224 | Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis |
| Q92530826 | Natural history of prediabetes in older adults from a population-based longitudinal study |
| Q38811478 | New directions for diabetes prevention and management in behavioral medicine |
| Q51245779 | New insights from continuous glucose monitoring into the route to diabetes. |
| Q50179665 | Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction |
| Q90572525 | Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study |
| Q37106937 | Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications |
| Q47168303 | Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia |
| Q90655369 | Regression from prediabetes to normal glucose regulation: State of the science |
| Q92258760 | Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study |
| Q90634754 | Risk of developing pre-diabetes or diabetes over time in a cohort of Mexican health workers |
| Q53695913 | The Vasculature in Prediabetes. |
| Q38264363 | The role of lifestyle change for prevention of cardiovascular disease in diabetes |
| Q36338832 | Tools for Successful Weight Management in Primary Care |
| Q26783350 | Treatment of prediabetes |
| Q89258111 | Type 2 diabetes |
| Q30844163 | Understanding type 2 diabetes mellitus screening practices among primary care physicians: a qualitative chart-stimulated recall study |
| Q36932841 | Urban and rural prevalence of diabetes and pre-diabetes and risk factors associated with diabetes in Tanzania and Uganda |
| Q42408405 | Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making. |
| Q90686275 | Wellness Coaching to Improve Lifestyle Behaviors Among Adults With Prediabetes: Patients' Experience and Perceptions to Participation |
| Q52642787 | When Should "Pre" Carry as Much Weight in the Diabetes Comorbidity Debate? Insights From a Population-Based Survey. |
Search more.